Synapse Medicine Keynote – AI for Health
Dr Clément Goehrs
CEO & Co-Founder
Synapse Medicine AI for Health Keynote On-Demand
Improving Patient Safety for Telemedicine Platforms with Medication Intelligence
The COVID-19 pandemic has been playing an important role in the large adoption of telemedicine around the world. According to a recent study from McKinsey, 46% of consumers in the U.S were using telemedicine in June 2020, while they were 11% a year earlier. However, the growth of teleconsultations can increase the risk of inadequate use of medication which can lead to hospitalizations and deaths. Hence, it is crucial for telemedicine platforms to secure their prescriptions.
In this keynote session, Dr. Clement Goehrs, co-founder & CEO at Synapse Medicine, breaks down how medication intelligence helps telemedicine platforms improve patient safety by securing prescriptions.
WHAT CAN YOU EXPECT FROM THIS SESSION?
- An overview of telemedicine adoption in 2020
- The impact of medication intelligence on telemedicine’s patient safety
- Exclusive Synapse Medicine data
- Keynote session slides download link
Retrospective: A Look Back at Synapse Medicine's 2020 Highlights Reel
Several Synapse Medicine employees contributed to this article, which will revisit many of the great projects the compan…
How we built a COVID-19 platform that has helped 700,000 people and counting ー all in just 72 hours
At exactly 11:38 a.m. on Saturday 14 March, French Health Minister Olivier Véran tweeted the following message: “#COVID-…